GlassScriptPhysician profile
Delaney Rodriguez
NPI 1427690890
$3,659.43
in general payments reported to CMS, 2019-2025
33 companies · $1,509 in 2025
The $1,509 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,154 · 2024: $997 · 2025: $1,509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,442 · Education: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,441.76 |
| Education | $217.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $745.65 | 2023-2025 | Tezspire, Airsupra, Breztri |
| Regeneron Healthcare Solutions, INC. | $450.61 | 2023-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $441.80 | 2023-2025 | Xywav |
| Genzyme Corporation | $367.36 | 2023-2025 | |
| Glaxosmithkline, LLC. | $303.22 | 2023-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.35 | 2023-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Inogen, INC. | $94.55 | 2024-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $94.12 | 2023-2025 | Lumryz |
| Takeda Pharmaceuticals U.S.A., INC. | $91.11 | 2023-2025 | Glassia, Hyqvia |
| Merck Sharp & Dohme LLC | $79.55 | 2024-2025 | Zerbaxa, Keytruda |
| Philips North America LLC | $78.33 | 2023-2024 | (Ak6) Vest Therapy |
| Mylan Specialty L.P. | $63.59 | 2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $61.62 | 2025 | Opsumit, Uptravi |
| Viatris Specialty LLC | $47.28 | 2025 | Yupelri |
| Alk-Abello, INC | $46.18 | 2025 | Odactra, Ragwitek, Grastek |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $35.78 | 2024 | |
| Insmed, INC. | $35.77 | 2025 | Arikayce, Brinsupri |
| Pulmonx Corporation | $35.70 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Pfizer INC. | $29.63 | 2023-2024 | |
| Sk Life Science, INC. | $28.73 | 2023 | |
| Mallinckrodt Hospital Products INC. | $25.30 | 2025 | Acthar |
| Axsome Therapeutics, INC. | $24.03 | 2025 | Sunosi |
| Lilly USA, LLC | $22.99 | 2025 | Zepbound, Mounjaro |
| Microtransponder, INC. | $22.66 | 2024 | |
| Globus Medical, INC. | $21.77 | 2025 | Senza |
| Ucb, INC. | $21.68 | 2025 | Briviact |
| Otsuka America Pharmaceutical, INC. | $21.02 | 2023 | Rexulti |
| Resmed Corp | $20.12 | 2025 | |
| Eisai INC. | $20.00 | 2024 | |
| Xeris Pharmaceuticals, INC. | $19.92 | 2025 | Gvoke Hypopen |
| Grifols USA, LLC | $19.51 | 2023 | Gamunex-C |
| Electromed, INC. | $18.27 | 2023 | Smartvest |
| Scilex Pharmaceuticals INC. | $15.23 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Delaney Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.